AMLX: Amylyx Pharmaceuticals, Inc. Common Stock Company Profile & Statistics

About

Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Joshua B. Cohen

Headquarters

43 Thorndike St.
Cambridge, MA 02141, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

123

Amylyx Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

352.19M

Enterprise Value

274.80M

Enterprise Value/EBITDA(ttm)

-0.85

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.61

Price to Book(mrq)

1.22

Price to Cash(ytd)

5.88

Profitability

Gross Margin(ttm)

199.83%

Operating Margin(ttm)

Profit Margin(ttm)

-1214.58%

Return on Equity(ttm)

-36.97%

Return on Invested Capital(ttm)

-124.28%

Return on Assets(ttm)

-29.61%

Income Statement

Revenue(ttm)

87.37M

Revenue Per Share(ttm)

0.99

Gross Profit(ttm)

-37.26M

EBITDA(ttm)³

-323.68M

Net Income Available to Common(ttm)

-301.74M

Diluted EPS(ttm)

-3.82

Share Statistics

Beta (5Y Monthly)

-0.54

52-Week Change

98.95%

S&P 500 52-Week Change

5.42%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

88.60M

Dividend Yield

0.00%

Float⁴

60.53M

% Held by Insiders

11.70%

% Held by Institutions

95.84%

Balance Sheet

Total Cash(mrq)

176.50M

Total Cash Per Share(mrq)

1.99

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.67%

Quick Ratio(mrq)

4.55%

Book Value Per Share(mrq)

2.40

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.46

Free Cash Flow(ytd)

-204.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AMLX

Amylyx Pharmaceuticals, Inc. Common Stock

Amylyx Pharmaceuticals, Inc. Common Stock Profile